The Critical Limb Ischemia Study conducted in AIMS

Stempeutics Research, a biotechnology company developing stem cell based medicinal products, is all set to introduce its investigational new drug (IND) in India by 2012. The drug is being developed in India is for acute myocardial infarction and critical limb ischemia. The Critical Limb Ischemia Study is being conducted in Amrita Institute of Medical Sciences, Kochi; Sir Ganga Ram Hospital, New Delhi; M S Ramaiah Memorial Hospital, Bangalore and in Bhagawan Mahaveer Jain Heart Centre, Bangalore.

Amrita Institute of Medical Sciences, Organises Medical Camp at Aluva

The Amrita Institute of Medical Sciences, in association with the Keezhumad Panchayat Powra Samrakshana Samiti, will organise a medical camp at Kuttamassery Government H S on Saturday.

AIMS Organise a Medical Camp

The Amrita Institute of Medical Sciences, in association with the Keezhumad Panchayat Powra Samrakshana Samiti, will organise a medical camp at Kuttamassery Government H S on Saturday.

SBI hands over intensive care ambulance to AIMS

The State Bank of India on Tuesday handed over a fullfledged intensive care ambulance unit to the Amrita Institute of Medical Sciences.